News
Biotech company Regeneron (NASDAQ:REGN) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.6% ...
The new data join an emerging literature linking the increased incidence of bullous pemphigoid in recent years with certain medications, and specifically, DPP-4 inhibitors, a class of type 2 ...
DUBLIN--(BUSINESS WIRE)--The "Bullous pemphigoid - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. The "Bullous Pemphigoid - Pipeline Insight, 2023 ...
Bullous pemphigoid is a potentially debilitating autoimmune bullous disease presenting with urticarial plaques, subepidermal bullae, erosions, and pruritus, classically in elderly individuals.
Bullous pemphigoid is a rare autoimmune disease that causes painful chronic blisters and welts. it typically strikes elderly people who already have one or more diseases or are in poor health.
The mean Bullous Pemphigoid Disease Area Index (BPDAI) decreased from 32 on day 1 to 19.6 on day 42. A BPDAI reduction of at least 8 points was recorded in seven of the nine patients, while three ...
Pronounced “BULL-us PEM-fih-goyd” (with bullous being the medical term for a large blister), Bullous Pemphigoid is a rare, autoimmune, chronic skin disorder that causes large, fluid-fil… ...
The causes of bullous pemphigoid, which typically develops at age 70 and older, are not fully understood. There is evidence that in some people, it may be triggered by medications.
Throughout the study period, 9304 patients were prescribed DPP4Is, and bullous pemphigoid developed in 8. Of those, 6 had a non-inflammatory form, and tests were negative for the antibody in 5.
Bullous pemphigoid (BP) is a common autoimmune subepidermal blistering disease that can be controlled with topical corticosteroids when mild. However, more severe cases are difficult to treat.
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Bullous pemphigoid - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Bullous pemphigoid - Pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results